Customized autoantibodies (autoAbs) profiling to predict and monitor immune-related adverse events (irAEs) in patients receiving immune checkpoint inhibitors (ICI)

被引：0
|
作者：
Genta, Sofia
Keshavarzi, Sareh
Yee, Noelle
Heirali, Alya
Hansen, Aaron Richard
Siu, Lillian L.
Saibil, Samuel
Stayner, Lee-Anne
Yanekina, Maryia
Sauder, Maxwell
Salawu, Abdulazeez
Spiliopoulou, Pavlina
Vornicova, Olga
Vilbert, Maysa Tamara Silveira
Butler, Marcus O.
Bedard, Philippe L.
Razak, Albiruni Ryan Abdul
Coburn, Bryan
Chruscinski, Andrzej
Spreafico, Anna
机构：
[1] Univ Hlth Network, Div Med Oncol & Hematol, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Princess Margaret Canc Ctr, Dept Biostatist, Toronto, ON, Canada
[3] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada
[4] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada
[5] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[6] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada
[7] Princess Margaret Canc Ctr, Toronto, ON, Canada
[8] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[9] Univ Hlth Network, Toronto, ON, Canada
[10] Univ Hlth Network, Toronto Gen Hosp, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2528
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Immune-related adverse events (IrAEs) in patients receiving immune checkpoint inhibitors
    Ferrarini, Alessia
    Benfaremo, Devis
    Rossetti, Giulia
    Morgese, Francesca
    Pomponio, Giovanni
    Berardi, Rossana
    Gabrielli, Armando
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18
  • [2] Rheumatic immune adverse events related to immune checkpoint inhibitors-(IrAEs related to ICI)
    Tingry, Thomas
    Massy, Emmanuel
    Piperno, Muriel
    Auroux, Maxime
    Kostine, Marie
    Maillet, Denis
    Amini-Adle, Mona
    Fabien, Nicole
    Estublier, Charline
    Goncalves, David
    Girard, Nicolas
    Confavreux, Cyrille B.
    BULLETIN DU CANCER, 2021, 108 (06) : 643 - 653
  • [3] Predictors of endocrine immune-related adverse events (irAEs) in patients treated with immune checkpoint inhibitors (ICI) in routine clinical practice
    Kozhevnikov, Alexander
    Mkrtumyan, Ashot
    Feoktistova, Polina Serrgeevna
    Filonenko, Daria
    Polshina, Natalya
    Volkova, Ekaterina
    Grechukhina, Katerina
    Bykonya, Irina
    Zhukova, Lyudmila
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Association of efficacy and immune-related adverse events (irAEs) in patients with NSCLC receiving immune-checkpoint inhibitors (ICIs)
    Riudavets Melia, M.
    Gabriela Sullivan, I.
    Barba Joaquin, A.
    Anguera Palacios, G.
    del Carpio, L. P.
    Molto Valiente, C.
    Camacho Arellano, S. D.
    Moron Asensio, S.
    Gomila Pons, P.
    Andres Granyo, M.
    Castillo Villegas, D.
    Facundo Molas, C.
    Garcia Planella, E.
    Gonzalez Blanco, C.
    Barnadas Molins, A.
    Gich Saladich, I.
    Majem Tarruella, M.
    ANNALS OF ONCOLOGY, 2018, 29 : 509 - 509
  • [5] Impact of obesity on the risk of immune-related adverse events (irAEs) among patients receiving immune-checkpoint inhibitors (ICI) treatment: A retrospective cohort study
    Elsaid, Mohamed I.
    Paskett, Electra D.
    Shendre, Aditi
    Manne, Ashish
    Li, Lang
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Impact of patient education on immune-related adverse events (irAEs) during immune checkpoint inhibitor (ICI)
    Berger, V. A.
    Jube, C.
    Forestier, A.
    Mitonneau, C.
    Humeau, H.
    Limouzin, S.
    Tiercin, M.
    Morliere, L.
    Geoffrois, L.
    Cabart, M.
    Bertholet, M.
    Llambrich-Molines, C.
    Breysse, S.
    Laghouati, S.
    Beaumont, N.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1285 - S1285
  • [7] Patterns of immune-related adverse events (irAEs) in adolescent and young adult (AYA) patients with melanoma receiving immune checkpoint inhibitors (ICIs)
    He, Jiasen
    John, Ida
    Afridi, Faraz
    Sun, Mianen
    Wang, Yinghong
    Roth, Michael
    McQuade, Jennifer Leigh
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Molecular Mechanisms of Cutaneous Immune-Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitors
    Teng, Yi-Shan
    Yu, Sebastian
    CURRENT ONCOLOGY, 2023, 30 (07) : 6805 - 6819
  • [9] Cutaneous Immune-Related Adverse Events (irAEs) to Immune Checkpoint Inhibitors: A Dermatology Perspective on Management
    Muntyanu, Anastasiya
    Netchiporouk, Elena
    Gerstein, William
    Gniadecki, Robert
    Litvinov, Ivan V.
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2021, 25 (01) : 59 - 76
  • [10] Eosinophilia during treatment of immune checkpoint inhibitors (ICIs) to predict succeeding onset of immune-related adverse events (irAEs).
    Kizawa, Rika
    Miura, Yuji
    Oda, Yasuhiro
    Nagaoka, Yukiko
    Ozaki, Yukinori
    Kondoh, Chihiro
    Moriguchi, Shuhei
    Takahashi, Yui
    Ogawa, Kazumasa
    Tanabe-Hashimoto, Yuko
    Taniguchi, Shuichi
    Okaneya, Toshikazu
    Kishi, Akiko
    Hayashi, Nobukazu
    Kishi, Kazuma
    Takano, Toshimi
    Masuda, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345